Abstract
Background: Current guidelines recommend fine needle aspiration (FNA) in patients with severe acute pancreatitis (SAP) and signs of sepsis. Infected necrosis is an indication for surgery. We found high mortality in patients operated early in the course of the disease. Currently we treat patients with SAP conservatively without FNA. We evaluated the impact of this concept on outcome in SAP. Methods: Prospective analysis of patients with SAP since 09/2003 (group 1) and comparison with retrospectively analyzed patients from 03/2000 until 08/2003 (group 2). Results: Group 1: 20 consecutive patients with SAP were treated according to the new concept. All patients required ICU treatment. One patient had early surgery and died. Six pts. needed late surgery due to secondary complications and survived. One out of 13 conservatively treated patient died. CT-guided drainage was performed in one patient with abdominal compartment due to pseudocyst formation. All patients in group 2 were operated following positive FNA. 9 patients died in this group. Degree of pancreatic damage was the same in both groups as well as percentage of endocrine insufficiency. All pts of both groups received antibiotic prophylaxis. Prognostic scores indicated a severe course of the disease in both groups (no statistical difference): APACHE II was 16 ± 2.2 (group 1) vs. 19.8 ± 1.7 (group 2) and SOFA score 6.5 ± 1.1 and 8.7 ± 1.4, respectively. CRP on day 3 was 283 ± 25 (group 1) and 243 ± 21 in group 2, CTSI score was 7.9 ± 0.5 (group 1) and 7.8 ± 0.5 (group 2). Only mortality differed significantly with 10% in group 1 vs. 45 % in group 2. Conclusion: Patients with SAP treated conservatively without FNA had a significant lower mortality compared with patients treated in accordance to current guidelines. Difference in treatment included avoidance of FNA and surgery within the first 3-4 weeks. We suggest that FNA should be avoided within the first 3 weeks of SAP in a stable patient regardless of secondary organ complications since surgery increases mortality during this early phase independent from the infection of pancreatic necrosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.